The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Immune Repertoire Sequencing Market Research Report 2025
Synopsis
Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body’s autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.
The global Immune Repertoire Sequencing market was valued at US$ 103.3 million in 2023 and is anticipated to reach US$ 128.8 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
North American market for Immune Repertoire Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immune Repertoire Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Immune Repertoire Sequencing in Bioinformatics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Immune Repertoire Sequencing include Adaptive Biotechnologies & Amgen, BGI, Alacris Theranostics, CD Genomics, AptaIT, ArcherDX, Roche Holding and ThermoFisher Scietific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immune Repertoire Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Repertoire Sequencing.
Report Scope
The Immune Repertoire Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immune Repertoire Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune Repertoire Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Adaptive Biotechnologies & Amgen
BGI
Alacris Theranostics
CD Genomics
AptaIT
ArcherDX
Roche Holding
ThermoFisher Scietific
Segment by Type
Pyro-Sequencing
Dye-Terminating Sequencing
Others
Segment by Application
Bioinformatics
Hematology
Immunology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immune Repertoire Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body’s autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.
The global Immune Repertoire Sequencing market was valued at US$ 103.3 million in 2023 and is anticipated to reach US$ 128.8 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
North American market for Immune Repertoire Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immune Repertoire Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Immune Repertoire Sequencing in Bioinformatics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Immune Repertoire Sequencing include Adaptive Biotechnologies & Amgen, BGI, Alacris Theranostics, CD Genomics, AptaIT, ArcherDX, Roche Holding and ThermoFisher Scietific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immune Repertoire Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Repertoire Sequencing.
Report Scope
The Immune Repertoire Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immune Repertoire Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune Repertoire Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Adaptive Biotechnologies & Amgen
BGI
Alacris Theranostics
CD Genomics
AptaIT
ArcherDX
Roche Holding
ThermoFisher Scietific
Segment by Type
Pyro-Sequencing
Dye-Terminating Sequencing
Others
Segment by Application
Bioinformatics
Hematology
Immunology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immune Repertoire Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune Repertoire Sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pyro-Sequencing
1.2.3 Dye-Terminating Sequencing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Immune Repertoire Sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Bioinformatics
1.3.3 Hematology
1.3.4 Immunology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immune Repertoire Sequencing Market Perspective (2019-2030)
2.2 Immune Repertoire Sequencing Growth Trends by Region
2.2.1 Global Immune Repertoire Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immune Repertoire Sequencing Historic Market Size by Region (2019-2024)
2.2.3 Immune Repertoire Sequencing Forecasted Market Size by Region (2025-2030)
2.3 Immune Repertoire Sequencing Market Dynamics
2.3.1 Immune Repertoire Sequencing Industry Trends
2.3.2 Immune Repertoire Sequencing Market Drivers
2.3.3 Immune Repertoire Sequencing Market Challenges
2.3.4 Immune Repertoire Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune Repertoire Sequencing Players by Revenue
3.1.1 Global Top Immune Repertoire Sequencing Players by Revenue (2019-2024)
3.1.2 Global Immune Repertoire Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Immune Repertoire Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immune Repertoire Sequencing Revenue
3.4 Global Immune Repertoire Sequencing Market Concentration Ratio
3.4.1 Global Immune Repertoire Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune Repertoire Sequencing Revenue in 2023
3.5 Immune Repertoire Sequencing Key Players Head office and Area Served
3.6 Key Players Immune Repertoire Sequencing Product Solution and Service
3.7 Date of Enter into Immune Repertoire Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune Repertoire Sequencing Breakdown Data by Type
4.1 Global Immune Repertoire Sequencing Historic Market Size by Type (2019-2024)
4.2 Global Immune Repertoire Sequencing Forecasted Market Size by Type (2025-2030)
5 Immune Repertoire Sequencing Breakdown Data by Application
5.1 Global Immune Repertoire Sequencing Historic Market Size by Application (2019-2024)
5.2 Global Immune Repertoire Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immune Repertoire Sequencing Market Size (2019-2030)
6.2 North America Immune Repertoire Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immune Repertoire Sequencing Market Size by Country (2019-2024)
6.4 North America Immune Repertoire Sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immune Repertoire Sequencing Market Size (2019-2030)
7.2 Europe Immune Repertoire Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immune Repertoire Sequencing Market Size by Country (2019-2024)
7.4 Europe Immune Repertoire Sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immune Repertoire Sequencing Market Size (2019-2030)
8.2 Asia-Pacific Immune Repertoire Sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immune Repertoire Sequencing Market Size (2019-2030)
9.2 Latin America Immune Repertoire Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immune Repertoire Sequencing Market Size by Country (2019-2024)
9.4 Latin America Immune Repertoire Sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune Repertoire Sequencing Market Size (2019-2030)
10.2 Middle East & Africa Immune Repertoire Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adaptive Biotechnologies & Amgen
11.1.1 Adaptive Biotechnologies & Amgen Company Detail
11.1.2 Adaptive Biotechnologies & Amgen Business Overview
11.1.3 Adaptive Biotechnologies & Amgen Immune Repertoire Sequencing Introduction
11.1.4 Adaptive Biotechnologies & Amgen Revenue in Immune Repertoire Sequencing Business (2019-2024)
11.1.5 Adaptive Biotechnologies & Amgen Recent Development
11.2 BGI
11.2.1 BGI Company Detail
11.2.2 BGI Business Overview
11.2.3 BGI Immune Repertoire Sequencing Introduction
11.2.4 BGI Revenue in Immune Repertoire Sequencing Business (2019-2024)
11.2.5 BGI Recent Development
11.3 Alacris Theranostics
11.3.1 Alacris Theranostics Company Detail
11.3.2 Alacris Theranostics Business Overview
11.3.3 Alacris Theranostics Immune Repertoire Sequencing Introduction
11.3.4 Alacris Theranostics Revenue in Immune Repertoire Sequencing Business (2019-2024)
11.3.5 Alacris Theranostics Recent Development
11.4 CD Genomics
11.4.1 CD Genomics Company Detail
11.4.2 CD Genomics Business Overview
11.4.3 CD Genomics Immune Repertoire Sequencing Introduction
11.4.4 CD Genomics Revenue in Immune Repertoire Sequencing Business (2019-2024)
11.4.5 CD Genomics Recent Development
11.5 AptaIT
11.5.1 AptaIT Company Detail
11.5.2 AptaIT Business Overview
11.5.3 AptaIT Immune Repertoire Sequencing Introduction
11.5.4 AptaIT Revenue in Immune Repertoire Sequencing Business (2019-2024)
11.5.5 AptaIT Recent Development
11.6 ArcherDX
11.6.1 ArcherDX Company Detail
11.6.2 ArcherDX Business Overview
11.6.3 ArcherDX Immune Repertoire Sequencing Introduction
11.6.4 ArcherDX Revenue in Immune Repertoire Sequencing Business (2019-2024)
11.6.5 ArcherDX Recent Development
11.7 Roche Holding
11.7.1 Roche Holding Company Detail
11.7.2 Roche Holding Business Overview
11.7.3 Roche Holding Immune Repertoire Sequencing Introduction
11.7.4 Roche Holding Revenue in Immune Repertoire Sequencing Business (2019-2024)
11.7.5 Roche Holding Recent Development
11.8 ThermoFisher Scietific
11.8.1 ThermoFisher Scietific Company Detail
11.8.2 ThermoFisher Scietific Business Overview
11.8.3 ThermoFisher Scietific Immune Repertoire Sequencing Introduction
11.8.4 ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2019-2024)
11.8.5 ThermoFisher Scietific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
